Literature DB >> 29247008

Structural basis for lipid binding and mechanism of the Mycobacterium tuberculosis Rv3802 phospholipase.

Christopher M Goins1, Celine M Schreidah1, Steven Dajnowicz1,2, Donald R Ronning3.   

Abstract

The Mycobacterium tuberculosis rv3802c gene encodes an essential enzyme with thioesterase and phospholipase A activity. Overexpression of Rv3802 orthologs in Mycobacterium smegmatis and Corynebacterium glutamicum increases mycolate content and decreases glycerophospholipids. Although a role in modulating the lipid composition of the unique mycomembrane has been proposed, the true biological function of Rv3802 remains uncertain. In this study, we present the first M. tuberculosis Rv3802 X-ray crystal structure, solved to 1.7 Å resolution. On the basis of the binding of PEG molecules to Rv3802, we identified its lipid-binding site and the structural basis for phosphatidyl-based substrate binding and phospholipase A activity. We found that movement of the α8-helix affords lipid binding and is required for catalytic turnover through covalent tethering. We gained insights into the mechanism of acyl hydrolysis by observing differing arrangements of PEG and water molecules within the active site. This study provides structural insights into biological function and facilitates future structure-based drug design toward Rv3802.

Entities:  

Keywords:  Mycobacterium tuberculosis; Rv3802; alpha/beta-Hydrolase; drug discovery; hydrolase; phosphatidylinositol; phospholipase A

Mesh:

Substances:

Year:  2017        PMID: 29247008      PMCID: PMC5787812          DOI: 10.1074/jbc.RA117.000240

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

Review 3.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

4.  Phosphatidylinositol is an essential phospholipid of mycobacteria.

Authors:  M Jackson; D C Crick; P J Brennan
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

5.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.

Authors:  Karsten Fischer; Emmanuel Scotet; Marcus Niemeyer; Heidrun Koebernick; Jens Zerrahn; Sophie Maillet; Robert Hurwitz; Mischo Kursar; Marc Bonneville; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 7.  Tuberculosis.

Authors:  Madhukar Pai; Marcel A Behr; David Dowdy; Keertan Dheda; Maziar Divangahi; Catharina C Boehme; Ann Ginsberg; Soumya Swaminathan; Melvin Spigelman; Haileyesus Getahun; Dick Menzies; Mario Raviglione
Journal:  Nat Rev Dis Primers       Date:  2016-10-27       Impact factor: 52.329

8.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.

Authors:  Fabian Sievers; Andreas Wilm; David Dineen; Toby J Gibson; Kevin Karplus; Weizhong Li; Rodrigo Lopez; Hamish McWilliam; Michael Remmert; Johannes Söding; Julie D Thompson; Desmond G Higgins
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

9.  Structural basis for selective recognition of acyl chains by the membrane-associated acyltransferase PatA.

Authors:  David Albesa-Jové; Zuzana Svetlíková; Montse Tersa; Enea Sancho-Vaello; Ana Carreras-González; Pascal Bonnet; Pedro Arrasate; Ander Eguskiza; Shiva K Angala; Javier O Cifuente; Jana Korduláková; Mary Jackson; Katarína Mikušová; Marcelo E Guerin
Journal:  Nat Commun       Date:  2016-03-11       Impact factor: 14.919

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  4 in total

1.  Biochemical and microbiological evaluation of N-aryl urea derivatives against mycobacteria and mycobacterial hydrolases.

Authors:  Abhishek Vartak; Christopher Goins; Vinicius Calado Nogueira de Moura; Celine M Schreidah; Alexander D Landgraf; Boren Lin; Jianyang Du; Mary Jackson; Donald R Ronning; Steven J Sucheck
Journal:  Medchemcomm       Date:  2019-06-04       Impact factor: 3.597

2.  Characterization of Tetrahydrolipstatin and Stereoderivatives on the Inhibition of Essential Mycobacterium tuberculosis Lipid Esterases.

Authors:  Christopher M Goins; Thanuja D Sudasinghe; Xiaofan Liu; Yanping Wang; George A O'Doherty; Donald R Ronning
Journal:  Biochemistry       Date:  2018-04-10       Impact factor: 3.162

3.  Mycolicibacterium smegmatis, Basonym Mycobacterium smegmatis, Expresses Morphological Phenotypes Much More Similar to Escherichia coli Than Mycobacterium tuberculosis in Quantitative Structome Analysis and CryoTEM Examination.

Authors:  Hiroyuki Yamada; Masashi Yamaguchi; Yuriko Igarashi; Kinuyo Chikamatsu; Akio Aono; Yoshiro Murase; Yuta Morishige; Akiko Takaki; Hiroji Chibana; Satoshi Mitarai
Journal:  Front Microbiol       Date:  2018-09-11       Impact factor: 5.640

4.  Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Yu-Shuai Han; Jia-Xi Chen; Zhi-Bin Li; Jing Chen; Wen-Jing Yi; Huai Huang; Li-Liang Wei; Ting-Ting Jiang; Ji-Cheng Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.